Literature DB >> 2266156

Analysis of the first polar body: preconception genetic diagnosis.

Y Verlinsky1, N Ginsberg, A Lifchez, J Valle, J Moise, C M Strom.   

Abstract

In women who are heterozygous for a genetic disease, genetic analysis of the first polar body allows the identification of oocytes that contain the maternal unaffected gene. These oocytes can be fertilized and transferred to the mother without risk of establishing a pregnancy with a genetically abnormal embryo. We have demonstrated that removal of the first polar body has no effect on subsequent fertilization rates or embryonic growth to the blastocyst stage. We have developed a PCR technique to successfully analyze the PI type Z and PI type M genotypes of alpha-1-antitrypsin deficiency and applied this technique for a couple at risk for PI type ZZ alpha-1-antitrypsin deficiency. After standard IVF treatment to stimulate multiple follicle development, eight oocytes were aspirated transvaginally. Polar bodies were removed by micromanipulation from seven oocytes and fertilization occurred in six cases. PCR analysis was successful in five oocytes. One was PI type M, two were PI type Z and two were heterozygous MZ due to crossing over. Embryos from the two oocytes containing the unaffected gene (polar body PI type Z) were transferred in the same cycle 48 h after insemination. No pregnancy was established. The accuracy of the polar body diagnosis was confirmed by polymerase chain reaction (PCR) analysis of an oocyte that failed to fertilize.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266156     DOI: 10.1093/oxfordjournals.humrep.a137192

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  61 in total

Review 1.  Tenth anniversary of preimplantation genetic diagnosis.

Authors: 
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

2.  Preimplantation diagnosis: an alternative to prenatal diagnosis of genetic and chromosomal disorders. International Working Group on Preimplantation Genetics.

Authors: 
Journal:  J Assist Reprod Genet       Date:  1999-04       Impact factor: 3.412

Review 3.  Molecular diagnostics in preimplantation genetic diagnosis.

Authors:  Alan R Thornhill; Karen Snow
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

4.  Singling out genetic disorders and disease.

Authors:  Martine De Rycke
Journal:  Genome Med       Date:  2010-10-06       Impact factor: 11.117

Review 5.  Preimplantation diagnosis (PGD)--a European clinician's point of view.

Authors:  Wilfried Feichtinger
Journal:  J Assist Reprod Genet       Date:  2004-01       Impact factor: 3.412

6.  The transcriptome of a human polar body accurately reflects its sibling oocyte.

Authors:  Adrian Reich; Peter Klatsky; Sandra Carson; Gary Wessel
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

7.  Confirmation rates of array-CGH in day-3 embryo and blastocyst biopsies for preimplantation genetic screening.

Authors:  P Mir; E Mateu; A Mercader; R Herrer; L Rodrigo; M Vera; V Peinado; M Milán-Sánchez; I Campos-Galindo; S García-Herrero; C Simón; C Rubio
Journal:  J Assist Reprod Genet       Date:  2015-11-07       Impact factor: 3.412

Review 8.  Preimplantation genetic diagnosis: present and future.

Authors:  Elpida Fragouli
Journal:  J Assist Reprod Genet       Date:  2007-06       Impact factor: 3.412

9.  Polar body transfer restores the developmental potential of oocytes to blastocyst stage in a case of repeated embryo fragmentation.

Authors:  Shuo-Ping Zhang; Chang-Fu Lu; Fei Gong; Ping-Yuan Xie; Liang Hu; Shun-Ji Zhang; Guang-Xiu Lu; Ge Lin
Journal:  J Assist Reprod Genet       Date:  2017-02-11       Impact factor: 3.412

10.  Pregnancy and Birth After a Two-Step PGD: Polar Body Diagnosis for Hemophilia A and Array CGH on Trophectoderm Cells for Chromosomal Aberrations.

Authors:  W Würfel; R Suttner; D Shakeshaft; V Mayer; U Schoen; K Sendelbach; M Locher; U Koehler; K Fiedler; G Krüsmann; E Holinski-Feder
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-08       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.